Abnova Corporation Company Profile
Abnova is the world largest monoclonal antibody manufacturer. We have a capacity of generating 500 mouse monoclonal antibodies per month. Rather than the traditional method of monoclonal antibody production, Abnova is taking a genomic/proteomic approach for the antibody development. Our goal is to have at least one antibody to every human expressed gene in human genome. We manufacture all our products, recombinant proteins and antibodies, in house in our stat-of-art facility in Taiwan. In most cases, we have multiple clones for our monoclonal antibodies, and their access is available to our industrial partners and collaborators from the academic institutions.
Location
9th Floor, No 108, Jou Tz Street, Neihu
Taipei
114
Taiwan
Contact
Fax: 011 886 2 8751 1166
Email: hr@abnova.com
News Articles
None
Drugs and Medications
None
PubMed Articles
None
Clinical Trials
None
Companies
Abnova is the world largest monoclonal antibody manufacturer. We have a capacity of generating 500 mouse monoclonal antibodies per month. Rather than the traditional method of monoclonal antibody prod...
Abnova is the world largest monoclonal antibody manufacturer. We have a capacity of generating 500 mouse monoclonal antibodies per month. Rather than the traditional method of monoclonal antibody prod...
More Information about "Abnova Corporation" on BioPortfolio
We have published hundreds of Abnova Corporation news stories on BioPortfolio along with dozens of Abnova Corporation Clinical Trials and PubMed Articles about Abnova Corporation for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Abnova Corporation Companies in our database. You can also find out about relevant Abnova Corporation Drugs and Medications on this site too.
